Sanofi says it's back to the drawing board on mRNA flu vaccinesSanofi, one of the top global vaccine makers, has stated that the current mRNA technology used in COVID-19 vaccines is not effective agains...
29 Jun, 2023, 11.11 AM IST
Countries which chose Covishield fared better than those that took mRNA vax: Adar PoonawallaCovovax, which is our Novavax product, is proven to be the best against Omicron and Omicron sub variants. It is also the only vaccine from ...
30 Jan, 2023, 12.24 AM IST
Cipla invests in Ethris for mRNA-based inhalation therapiesThe investment will facilitate a long-term strategic partnership between Cipla and Ethris for the development of messenger RNA (mRNA)-based...
29 Dec, 2022, 10.35 PM IST
mRNA technology-based Cancer vaccine boosts chances of survival: ModernaData revealed that using Merck's immunotherapy drug in combination with high-risk patients decreased their risk of dying.
13 Dec, 2022, 09.16 PM IST
WHO clears China's CanSino COVID vaccine for emergency useThe CanSino vaccine uses a harmless virus called an adenovirus to deliver the spike protein of the coronavirus into the body, which then pr...
19 May, 2022, 07.50 PM IST
Covishield offers longer immunity than mRNA jabs, says Adar PoonawallaPoonawalla, ET's Business Leader Of the Year for 2021, was optimistic that final approvals for administering Covovax to children would come...
29 Apr, 2022, 02.31 PM IST
Biological E to get mRNA technology from WHO to make COVID-19VaccinesWHO along with its partners will work with the Indian government and BE to develop a roadmap and put in place the necessary training and su...
05 Apr, 2022, 12.28 AM IST
Sanofi drops plans for messenger RNA vaccine against virusThe Paris-based company said it will continue to develop another vaccine candidate that is already undergoing late stage human trials. That...
28 Sep, 2021, 06.12 PM IST
AstraZeneca invests in Imperial's self-amplifying RNA technology with eye on future drugsVaxEquity, a startup founded by Imperial vaccinologist Robin Shattock, could receive up to $195 million if certain milestones are met, in a...
23 Sep, 2021, 12.03 PM IST
Biological E signs pact to manufacture Providence vaccineUnder the agreement, Providence will provide the necessary technology transfer for Biological E to manufacture mRNA vaccines in India with ...
08 Jul, 2021, 09.57 AM IST
India's Biological E. to make Providence Therapeutics' mRNA COVID-19 vaccineProvidence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary techn...
01 Jun, 2021, 05.20 PM IST
BioNTech to build mRNA manufacturing site in SingaporeThe biotech company said the Singapore production facility will have an estimated annual capacity of several hundred million doses of mRNA-...
10 May, 2021, 12.41 PM IST
Pfizer, Moderna COVID-19 vaccines highly effective even after first shot in real-world useThe study by the U.S. Centers for Disease Control and Prevention (CDC) evaluated the vaccines' ability to protect against infection, includ...
29 Mar, 2021, 10.06 PM IST
China starts work on plant for mRNA-based COVID-19 vaccine candidate: MediaThe mRNA technology contains instructions for human cells to make proteins that mimic part of the coronavirus, and is used in vaccines from...
21 Dec, 2020, 12.36 PM IST
Pfizer/BioNTech's Covid-19 vaccine: How the mRNA technology worksThe UK health secretary, Matt Hancock, tweeted that the NHS stands ready to start vaccinating early next week.
02 Dec, 2020, 02.01 PM IST
GSK collaborates with Germany's CureVac, set to take 10% stake for $163 millionBritain's GSK said on Monday it would invest 130 million pounds ($163 million) in German biotech firm CureVac for a 10% stake to work toget...
20 Jul, 2020, 12.17 PM IST
New customisable vaccine can fight Ebola, H1NI quickly: ResearchThe vaccines were able to stimulate both arms of the immune system -- a T cell response and an antibody response.
05 Jul, 2016, 04.12 PM IST